ライフサイエンスコーパス: OPCAB

1 OPCAB also had more trainee first operators (15.3% vs 12

2 OPCAB does not narrow the disparity in outcomes between

3 OPCAB had a significantly lower inpatient/30-day mortali

4 OPCAB is associated with fewer major adverse cardiac eve

5 OPCAB is associated with lower in-hospital mortality and

6 OPCAB is associated with similar long-term outcomes to C

7 OPCAB may provide complete revascularization that is dur

8 OPCAB patients were less likely to receive transfusion (

9 OPCAB patients were less likely to receive transfusion d

10 OPCAB surgery in patients with severe AAD is associated

11 Of the 5882 OPCAB, 76 (1.3%) converted to CPB.

12 less early neurocognitive dysfunction after OPCAB, and less renal insufficiency after OPCAB.

13 er OPCAB, and less renal insufficiency after OPCAB.

14 OPCAB, less myocardial enzyme release after OPCAB up to 24 hours, less early neurocognitive dysfunct

15 Risk-adjusted outcomes are superior after OPCAB versus on-pump coronary artery bypass for mortalit

16 ss blood loss and need for transfusion after OPCAB, less myocardial enzyme release after OPCAB up to

17 ith increased number of grafts (P=0.001) and OPCAB (P=0.01).

18 out the relative merits of standard CABG and OPCAB are difficult to reach from these varied randomize

19 dress different aspects of standard CABG and OPCAB.

20 The observed mortality of CONVERT, CPB, and OPCAB was 9.9%, 3.0%, and 1.6%, respectively, and the ob

21 entional coronary artery bypass grafting and OPCAB are safe procedures that improved the quality of l

22 used to assess the impact of black race and OPCAB on in-hospital outcomes (death, stroke, myocardial

23 groups with respect to treatment assignment (OPCAB or CABG on cardiopulmonary bypass).

24 hazard ratio 1.08, 95% CI 0.96 to 1.22), but OPCAB patients had higher rates of subsequent revascular

25 demonstrated no difference in survival, but OPCAB patients were more likely to require repeat revasc

26 Off-pump coronary artery bypass (OPCAB) grafting has been increasingly adopted in an effo

27 s trials of off-pump coronary artery bypass (OPCAB) have enrolled selected patients and have not rigo

28 k patients, off-pump coronary artery bypass (OPCAB) technique is associated with lower morbidity and

29 ) completed off-pump coronary artery bypass (OPCAB), whereas 456 (5.8%) were converted to on-pump (CO

30 omparison to on-pump coronary artery bypass, OPCAB reduces perioperative morbidity, but have failed t

31 tudy was to determine whether off-pump CABG (OPCAB) alters this gender-based disparity.

32 ortality and morbidity than either completed OPCAB or CPB patients.

33 statistically similar to men who had either OPCAB or CABG/CPB.

34 CONVERT also had more morbidity than either OPCAB or CPB.

35 New York State patients who underwent either OPCAB with median sternotomy (13 889 patients) or on-pum

36 One surgical session consisting of elective OPCAB or CABG with cardiopulmonary bypass.The surgeon ha

37 intervention (HR 0.98; 95% CI: 0.92-1.06 for OPCAB vs CPB; P=0.23).

38 95% confidence interval [CI]: 0.94-1.11 for OPCAB vs CPB; P=0.56) or freedom from death and reinterv

39 4/211) for on-pump CABG and 3.8% (8/211) for OPCAB (P=0.003).

40 oronary artery bypass grafting and 10.7% for OPCAB.

41 ion was 78.7% for on-pump CABG and 91.9% for OPCAB (P<0.001).

42 (95% CI, 755 dollars-3732 dollars) less for OPCAB (P =.002) and 1955 dollars (95% CI, -766 dollars t

43 ikely to receive transfusion (odds ratio for OPCAB, 0.80; P=0.037), and there were trends toward impr

44 Graft patency was similar for OPCAB and conventional CABG with cardiopulmonary bypass

45 Off-pump coronary artery bypass grafting (OPCAB) has been suggested to reduce the number of periop

46 ed off-pump coronary artery bypass grafting (OPCAB) in an effort to reduce the morbidity of surgical

47 In total, 13 226 patients had CABG: 5882 had OPCAB and 7344 had CPB, with a median follow-up of 6.2 y

48 s ratio, 0.72; 95% CI, 0.53 to 0.99) who had OPCAB had lower risk-adjusted odds of major adverse card

49 were compared between women and men who had OPCAB versus CABG/CPB.

50 examine the safety of routine application of OPCAB in these patients.

51 In many studies, the greatest benefit of OPCAB has been in high-risk patients.

52 However, the noninferiority of OPCAB with the prespecified margin could not be confirme

53 However, long-term outcome of OPCAB compared with conventional coronary artery bypass

54 the recent literature examining outcomes of OPCAB versus on-pump coronary artery bypass in high-risk

55 than whether they underwent standard CABG or OPCAB.

56 ry bypass or cardioplegia (off-pump CABG, or OPCAB) is superior to that performed with the heart-lung

57 ventional coronary artery bypass grafting or OPCAB surgery.

58 of experience performing CABG both off-pump (OPCAB) and on cardiopulmonary bypass (CPB).

59 of coronary artery bypass grafting off-pump (OPCAB) have a beneficial effect specifically in women ha

60 Patients receiving OPCAB had higher EuroSCOREs (median [quartiles]: 2.81 [1

61 likely to require repeat revascularization (OPCAB hazard ratio, 1.29; P=0.020).

62 A preliminary report showed OPCAB achieved improved inhospital outcomes, similar com

63 0-year survivals in each group were similar (OPCAB vs CPB: 96.7%, 87.9%, 72.1% vs 96.2%, 87.4%, 72.8%

64 f-pump coronary artery bypass graft surgery (OPCAB) has been performed for many years, but its use is

65 erm mortality, and whether off-pump surgery (OPCAB) modifies that risk.

66 training junior surgeons, demonstrates that OPCAB can be taught safely.

67 Multivariate analysis showed that OPCAB technique was associated with decreased stroke (P=

68 were investigated for patients who underwent OPCAB (641 patients) and CABG-cardiopulmonary bypass (50

69 Of these, 211 patients who underwent OPCAB were matched with 211 on-pump CABG patients by age

70 lected patients with angiographic follow-up, OPCAB achieved similar graft patency in the hospital and

71 Interventions were OPCAB or CABG/CPB, performed at the discretion of 14 fac

72 ncy, and it remains an open question whether OPCAB is associated with better outcomes than on-pump co

73 ction terms were constructed to test whether OPCAB surgery influences surgical results differently in

74 Fewer grafts tend to be performed with OPCAB than with standard CABG.

75 ale patients (n=3248) and those treated with OPCAB (n=4492) were older, had more comorbidities and hi

76 In contrast, women treated with OPCAB had outcomes statistically similar to men who had

77 Among women, OPCAB was associated with a significant reduction in dea

78 The 3-year OPCAB and on-pump survival rates for matched patients we